IMMUNEERING CORP - CLASS A (IMRX:NASDAQ)
$4.85 -0.14 (-2.8056%)
Analysed IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) News Sources
Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference
06-04-2026
yahoo.com
Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond
20-04-2026
yahoo.com
We're Hopeful That Immuneering (NASDAQ:IMRX) Will Use Its Cash Wisely
06-05-2026
yahoo.com
Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates
15-05-2026
yahoo.com
Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Cancer Patients at ASCO
01-06-2026
yahoo.com
Immuneering Appoints Andrew Gengos as Chief Financial Officer
15-06-2026
yahoo.com
Immuneering (IMRX) Upgraded to Buy: Here's What You Should Know
15-07-2026
yahoo.com
Publication in Cancer Research Details Atebimetinib’s Broad, Durable Preclinical Activity and Favorable Tolerability Across RAS- and RAF-Mutant Tumors via Deep Cyclic Inhibition
21-07-2026
yahoo.com
Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates
05-08-2026
yahoo.com
Immuneering Comments on Today’s FDA Approval in Second-Line Metastatic Pancreatic Cancer, Reiterates Focus on First-Line Patients
26-08-2026
yahoo.com
What is the current price of IMMUNEERING CORP - CLASS A (IMRX:NASDAQ)?
The current price of IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) is $4.85.
IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) since the previous trading day is $-0.14.
IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) since the previous trading day is -2.8056%.
What is the most recent average sentiment score for IMMUNEERING CORP - CLASS A (IMRX:NASDAQ)?
The most recent average sentiment score for IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for IMMUNEERING CORP - CLASS A (IMRX:NASDAQ)?
The most recent sentiment for IMMUNEERING CORP - CLASS A (IMRX:NASDAQ) is .
SEC-8K** Filing Available For IMMUNEERING CORP - CLASS A (IMRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.